SHMARQL

PARAMOUNT trial

<http://www.wikidata.org/entity/Q17148583>

clinical trial studying non-small-cell lung carcinoma
PARAMOUNT trial
rdfs:label
"PARAMOUNT trial"@en
skos:altLabel
"A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed plus Best Supportive Care versus Best Supportive Care Immediately Following Induction Treatment with Pemetrexed + Cisplatin"@en
schema:description
"clinical trial studying non-small-cell lung carcinoma"@en
schema:dateModified "2026-02-08T22:57:56+00:00"^^xsd:dateTime
schema:version 2461852103
wikibase:identifiers 3
wikibase:sitelinks 2
wikibase:statements 17
p:P1132 wd:statement/Q17148583-47835cff-4de7-f125-632a-3ff8ee3d67ff
p:P1476 wd:statement/Q17148583-4e9b5886-4a8e-3ebc-1d80-5f7fd39672be
p:P18 wd:statement/Q17148583-6b2fd5ca-4ea0-2847-61da-e9004549bbcb
p:P1813 wd:statement/Q17148583-a2ecf3e6-48a6-631c-6e77-a02c0549adf0
p:P2175 wd:statement/Q17148583-37F210BF-AE2B-43F9-A869-A0B7253DDFDD
p:P2899 wd:statement/Q17148583-D1695A31-F0B0-4A66-A5BD-65D03E622140
p:P3098 wd:statement/Q17148583-19313781-4bae-3bca-6d29-0ffe19de59f1
p:P31 wd:statement/Q17148583-d8e04016-4aa3-849f-e924-858b658669e5
p:P373 wd:statement/Q17148583-335EABF9-0914-4EF5-A646-E37DB035A69E
p:P4844 wd:statement/Q17148583-B3205276-954A-4A3A-9F8A-8BBE0B72CCCE
p:P580 wd:statement/Q17148583-a09ea56a-417e-29ee-293c-dc94e13e65d3
p:P582 wd:statement/Q17148583-2455b9e5-44d0-ef82-f50e-a34f356f8ad7
p:P6099 wd:statement/Q17148583-057EBFB3-69E9-4D46-83E8-1CF77C22FD07
p:P6366 wd:statement/Q17148583-532AE2B6-A04F-425C-A216-A20E9843B433
p:P646 wd:statement/Q17148583-E93E9204-27E6-412F-B70A-5E174C56D6E7
p:P8363 wd:statement/Q17148583-2CD681F0-EA89-4AE1-9A6B-6C7A335CB7AF
p:P859 wd:statement/Q17148583-8b5491d8-4d27-c923-e782-18dd44da21cc
p:direct-normalized/P6366 <https://makg.org/entity/2778879742>
wdt:P1132 939.0^^xsd:decimal
wdt:P1476 "A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer"@en
wdt:P18 <http://commons.wikimedia.org/wiki/Special:FilePath/PARAMOUNT%20Eli%20Lilly%20Informed%20Consent%20Document.djvu>
wdt:P1813 "PARAMOUNT trial"@en
wdt:P2175 lung cancer
wdt:P2899 18.0^^xsd:decimal
wdt:P3098 "NCT00789373"
wdt:P31 clinical trial
wdt:P373 "PARAMOUNT trial"
wdt:P4844 pemetrexed
wdt:P580 "2008-11-01T00:00:00+00:00"^^xsd:dateTime
wdt:P582 "2013-09-01T00:00:00+00:00"^^xsd:dateTime
wdt:P6099 phase III clinical trial
wdt:P6366 "2778879742"
wdt:P646 "/m/0x215cf"
wdt:P8363 interventional study
wdt:P859 Eli Lilly and Company
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata